Is TB-500 the same thing as thymosin beta-4?

No. Thymosin beta-4 is the full, naturally occurring 43-amino-acid peptide. Published analyses of products sold as TB-500 identified a seven-amino-acid acetylated fragment (Ac-LKKTETQ, residues 17–23) of Tβ4's active region. Sellers use the names inconsistently, which is one reason a certificate of analysis stating the exact sequence matters.

Is TB-500 FDA approved?

No — not for any use, in any form. In July 2026 the FDA's compounding advisory committee voted 8–6 to recommend TB-500 for the 503A bulks list — a non-binding advisory recommendation in a pending rulemaking that's moving toward broader legitimate access, not an approval or a finding of efficacy.

Is TB-500 banned in sports?

Yes. WADA prohibits thymosin beta-4 and its derivatives at all times, and TB-500 has a documented history as a banned substance in horse racing. If you are subject to drug testing at any level, do not use TB-500 in any format, including blends like KLOW.

Can TB-500 be absorbed under the tongue?

It's an open question nobody has measured. Full-length thymosin beta-4 is a multi-thousand-dalton protein — large for mucosal absorption — and no published study has measured TB-500 uptake from an oral or sublingual film in humans. We flag it because most sellers won't.

What Is TB-500? A Thymosin Beta-4 Fragment

Short answer: TB-500 is a synthetic fragment of thymosin beta-4, a natural protein deeply involved in how your cells move and reorganize — the machinery of tissue repair. Its preclinical research spans wound, cardiovascular and inflammation models, and an FDA advisory panel voted to recommend it for compounding. Here it lives inside the KLOW blend.

TB-500 is one of the most talked-about peptides in the recovery community — the "TB" in the legendary Wolverine stack — and its popularity comes from a genuinely interesting mechanism story: cell migration, the process by which repair cells travel to where they're needed. This page is the reference our TB-500 coverage links back to: what the compound actually is, why people love it, what the research has explored, and the one place it appears in our product line.

What TB-500 actually is

Start with the parent molecule. Thymosin beta-4 (Tβ4) is a naturally occurring 43-amino-acid peptide found in virtually all mammalian cells. First isolated from thymus tissue, it's now understood to be a major actin-binding molecule — actin being the structural protein that lets cells move, change shape, and reorganize. That role in cell migration is why Tβ4 drew research interest in wound, corneal, cardiovascular, and inflammation-related models, and why pharmaceutical programs (RegeneRx's RGN-259 ophthalmic and RGN-137 wound programs) took the full-length molecule into clinical development.

TB-500 is not that whole protein. Published chemical analyses of products sold as TB-500 — including anti-doping work on veterinary preparations (Ho et al., 2012; Maar et al., 2021) — identified the active content as Ac-LKKTETQ, a seven-amino-acid acetylated fragment corresponding to positions 17–23 of Tβ4's active region. In plain terms:

It is a fragment, not the full protein — a small piece of the active region, which is the piece researchers found most interesting.
The marketplace name is loose. Some sellers label full-length synthetic Tβ4 as "TB-500"; others sell the fragment. The same label can mean different molecules — one more reason a certificate of analysis matters.
It is not an approved medicine anywhere — it's a research-stage compound with a compelling parent-protein backstory.

Why people love it

TB-500's fame comes from the recovery community, where it's the mobility-and-remodeling half of the classic pairing with BPC-157 — the "Wolverine stack," a forum nickname riffing on the comic character's healing factor. The logic people discuss is complementary: BPC-157 occupies a repair-signaling lane while TB-500's parent molecule relates to cell migration and tissue remodeling.

Users frequently ask whether the two together feel different than either alone, and many users report choosing TB-500 specifically during heavy training blocks — attributed, unquantified community experience, which is where this compound's reputation genuinely lives. We report the questions because they're what people genuinely search; our full treatment of the nickname and how to think about it honestly is here: the Wolverine stack, explained.

What the research has explored

The parent molecule's research file is broad and genuinely intriguing:

Cell migration and tissue organization: Tβ4's defined role in actin dynamics is well-characterized basic science — the foundation everything else builds on. [preclinical evidence]
Wound, corneal, and cardiac models: cell and animal studies have examined Tβ4 and its fragments for effects on cell migration, blood-vessel growth (angiogenesis), and tissue-organization pathways. [preclinical evidence]
Pharmaceutical interest: full-length Tβ4 formulations went into formal drug-development programs — a signal of how seriously the parent molecule has been taken. [published human data] — pharmaceutical parent molecule, not TB-500 itself.
Analytical chemistry literature exists specifically on TB-500 because anti-doping labs needed to detect it — which tells you where the compound has actually been used. [published human data] — detection methods, not outcomes.

Regulatory momentum — moving the right direction

TB-500 is not an FDA-approved drug, so no product containing it can claim to treat, cure, or prevent anything — and neither will we. But the regulatory story just moved in a genuinely positive direction: at its July 23–24, 2026 meeting, the FDA's Pharmacy Compounding Advisory Committee reviewed TB-500 and voted 8–6 to recommend it for the 503A bulks list of substances compounding pharmacies may use. That's an advisory, non-binding step in an active rulemaking — realistically concluding around mid-to-late 2027 — and the direction of travel is toward more legitimate access, not less. We update this page when the regulatory text lands.

One practical note for competitors: TB-500 is prohibited in drug-tested sport. WADA bans thymosin beta-4 and its derivatives at all times, and the compound has a documented history in horse racing. If you compete under any testing regime, this one isn't for you — in any format, including blends.

The honest context

Here's the passage that doesn't help us sell, kept anyway: there are no controlled human outcome trials of TB-500 for any use — the compound's popularity is anecdote-driven, the human evidence file is essentially empty, and no one has measured TB-500 absorption from any oral or sublingual format. Whether a meaningful amount of a molecule in this size class crosses the oral mucosa from a dissolving film is a genuinely open question (we lay it out in detail on the KLOW blend pillar); any brand quoting you an absorption percentage for TB-500 is quoting a number that does not exist in the literature. [brand claim — unverified] whenever you see one. Findings about full-length thymosin beta-4 don't automatically transfer to a seven-residue fragment, either. And if you have an actual injury, the answer is a licensed clinician and evidence-based treatment — full stop. Adults 18+ only, never while pregnant or nursing, and loop in your healthcare provider.

Why TB-500 ended up in blends

Given the loose naming and the delivery unknowns, why is TB-500 in a blend at all? The answer is how this category formed. Multi-peptide "recovery" stacks grew out of compounding-clinic practice, where BPC-157 and TB-500 were the standard pairing; KLOW is the direct descendant, adding GHK-Cu and KPV to cover structure-side and signaling-side lanes. That's a rationale, not a tested hypothesis — but it explains why TB-500 rarely appears alone: its identity is bound up with the stack culture that made it famous.

Where TB-500 appears in our catalog

There is no standalone TB-500 product here — TB-500 appears in exactly one place:

KLOW sublingual strips: TB-500 alongside BPC-157, GHK-Cu, and KPV — the full four-peptide recovery stack in one needle-free strip, 20 strips per box. KLOW is available at open checkout. One sourcing fact, said plainly: KLOW does not yet have a third-party certificate of analysis on file.

The products we carry are sold under the InstaMed brand (Salt Lake City/Draper, Utah), and we sell as an authorized reseller. If your interest is specifically the better-studied stack partner, BPC-157 is available as a standalone strip with the deepest — still preclinical — research file in the category.

The bottom line

TB-500 is the cell-migration peptide with the most famous nickname in the recovery world, a genuinely intriguing preclinical file, and a regulatory trajectory that just turned in its favor. If the Wolverine stack is what brought you here, the honest route in this catalog is KLOW — four peptides, one strip, no needles. Order, bring your questions, and talk to your provider — the curious are welcome.

---

Explore this cluster

The rest of the TB-500 file: benefits, the cancer question answered calmly, safety and the route comparison.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

What Is TB-500? The Thymosin Beta-4 Fragment Explained